Malvern Panalytical, a market-leader in material characterization technologies, today (October 9) announces the acquisition of Dimer Instruments – a developer of cutting-edge technologies for biopharmaceutical analysis.

Headquartered in Santa Barbara, CA, Dimer Instruments was founded by industry veterans Dr. Stephen Minne and Dr. Michael Larkin, who bring deep expertise in biophysical characterization and analytical instrumentation. Malvern Panalytical has worked closely with Dimer Instruments since making a minority investment in the company on April 25 2024. The acquisition builds on this successful collaboration and brings the two organizations together to advance the development of new solutions for biopharmaceutical customers.

The first product to emerge from the collaboration is the Zetasizer Core, the only system to combine DLS, SLS and DSF technologies in a standard microwell plate format. This evolution of the existing Zetasizer product line offers biopharmaceutical scientists a differentiated, high-throughput and automation-friendly workflow, helping them keep pace with advances in drug discovery and make faster, more informed development decisions.

The acquisition brings Dimer Instruments’ specialist R&D capabilities to Malvern Panalytical’s scientific expertise, established Zetasizer platform and global reach. Together, helping create best-in-class products and services for customers and achieving shared long-term growth and value creation potential.

Speaking about the acquisition, Christian Sauber, President of Malvern Panalytical, said: “Our collaboration with Dimer Instruments has already delivered an important new product in the Zetasizer Core. Bringing our teams together will allow us to build on that success, develop new groundbreaking technologies and help biopharmaceutical scientists address some of their most critical workflow challenges.

“At Malvern Panalytical, we wake up every day to delight our customers and help them solve the problems that matter. Now with the Zetasizer Core, and an exciting pipeline of innovation on the way, we are extending our commitment to provide unparalleled solutions to our customers around the world.”

Stephen Minne, CEO of Dimer Instruments, adds: “The Zetasizer Core was born from a shared vision: to give biophysicists access to deeper insights through a faster, more scalable workflow. Dimer brought the technology, and Malvern Panalytical brought decades of scientific expertise, market understanding and customer insight. Together, we have created something truly differentiated.

“We have spent the last three years proving what this technology can do. As part of Malvern Panalytical, we now have an incredible opportunity to build on that foundation, accelerate the development of future innovations, and bring transformative new tools to laboratories around the world.”

Learn more about the launch of the Zetasizer Core:

• Zetasizer Core product page
• Watch now: Zetasizer Core Launch Event